6-MTH group results (IFRS)
Nov 8 (Reuters)-
Mitsubishi Chemical Group Corporation
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2022 Sep 30, 2021 Mar 31, 2023
LATEST YEAR-AGO COMPANY
RESULTS RESULT FORECAST
Sales 2.27 trln 1.89 trln 4.73 trln
(+20.4 pct) (+25.3 pct) (+18.8 pct)
Operating 118.35 153.14 242.00
(-22.7 pct) (-20.2 pct)
Pretax 121.97 147.17 234.00
(-17.1 pct) (-19.4 pct)
Net 73.94 85.17 132.00
(-13.2 pct) (-25.5 pct)
EPS Basic 52.02 yen 59.94 yen 92.84 yen
EPS Diluted 49.79 yen 55.13 yen
Ann Div 30.00 yen 30.00 yen
-Q2 Div 15.00 yen 15.00 yen
-Q4 Div 15.00 yen 15.00 yen
NOTE - Mitsubishi Chemical Group Corporation.
(Figures are reported based on international accounting rules (IFRS).)
If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half
dividend and Q4 to the second-half dividend announced before a new corporate law in
2006 allowed companies to pay and report dividends on a quarterly basis.
*Net - represents Net profit attributable to owners of the parent company.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4188.T
Recent news on Mitsubishi Chemical
See all newsJapan state-backed fund considering sale of chipmaking materials maker JSR, sources say
Japan state-backed fund considering sale of chipmaking materials maker JSR, sources say
Brief: Mitsubishi Chemical Group Corp - Notice Regarding Commencement Of Consideration On Spin-Off Of Petrochemicals Business As A Wholly Owned Subsidiary
Bain-backed Tanabe Pharma targets three new drug launches a year in Japan
2025/26 group results (IFRS)